Dna X Income Statement (2018-2025) | SONM

Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
12.24M11.95M14.45M15.93M13.26M11.96M20.50M24.12M25.80M26.84M27.57M13.43M16.78M11.52M15.02M22.64M16.72M11.19M16.21M
Cost of Revenue (Quarter)
2.18M2.19M3.09M-22.17M2.17M9.11M1.51M20.19M1.76M22.41M2.13M8.31M2.49M8.55M10.79M-20.25M3.24M10.35M2.45M
Gross Profit (Quarter)
2.46M2.65M1.78M-0.49M1.53M2.85M3.32M3.93M4.17M4.43M5.60M5.12M2.90M2.97M4.23M-0.18M8.36M0.84M1.82M
Operating items
Research & Development (Quarter)
4.66M3.67M5.49M3.87M4.17M2.72M-0.14M1.22M0.10M0.74M0.93M0.46M0.56M0.71M12.51M1.63M0.91M0.18M
Selling, General & Administrative (Quarter)
2.26M2.38M2.96M2.68M2.27M2.27M3.87M2.25M1.98M1.85M2.04M2.40M2.64M2.45M2.85M-4.84M2.84M3.22M3.16M-3.82M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)
4.59M3.09M4.05M4.70M2.17M2.07M0.73M1.52M1.76M1.83M2.13M3.05M2.49M6.44M3.04M-26.21M3.24M3.44M2.45M-11.86M
Operating Expenses (Quarter)
11.51M9.14M12.51M11.26M8.61M7.07M5.25M4.99M3.84M3.68M4.92M6.38M5.59M9.44M6.61M-18.54M7.71M7.58M5.80M-15.68M
Operating Income (Quarter)
-9.05M-6.49M-10.72M-11.74M-7.08M-4.22M-1.93M-1.06M0.33M0.75M0.69M-1.25M-2.69M-6.47M-2.38M8.44M0.65M-6.73M-3.98M4.66M
EBIT (Quarter)
-9.05M-6.49M-10.72M-11.74M-7.08M-4.22M-1.93M-1.06M0.33M0.75M0.69M-1.25M-2.69M-6.47M-2.38M8.44M0.65M-6.73M-3.98M4.66M
Non-operating items
Interest & Investment Income (Quarter)
-0.04M-0.04M-0.02M-0.00M-0.01M-0.01M-0.00M-0.02M-0.01M-0.09M-0.39M-0.52M-0.48M
Other Non Operating Income (Quarter)
-0.17M-0.12M-0.13M-0.04M-0.02M0.09M-0.18M0.60M0.01M-0.16M-0.06M-0.00M-0.09M-0.09M-0.02M0.45M0.04M-0.21M-0.16M-0.56M
Non Operating Income (Quarter)
-0.17M-0.12M-0.13M0.40M-0.02M0.09M-0.18M0.60M0.01M-0.16M-0.06M-0.00M-0.09M-0.09M-0.02M0.45M0.04M-0.21M-0.16M-0.56M
Net income details
EBT (Quarter)
-9.22M-6.61M-10.85M-11.78M-7.14M-4.16M-1.54M-1.06M0.34M0.58M0.62M-0.83M-2.78M-6.58M-2.40M8.87M0.59M-7.34M-4.66M3.45M
Tax Provisions (Quarter)
0.06M0.08M0.09M-0.06M0.07M0.06M0.07M-0.02M0.11M0.07M0.10M0.03M0.12M0.04M0.12M-0.04M0.13M0.14M0.09M
Profit After Tax (Quarter)
-9.28M-6.69M-10.94M-11.72M-7.21M-4.22M-1.61M-1.04M0.23M0.51M0.53M-1.35M-2.91M-6.62M-2.51M-21.61M0.46M-7.47M-4.75M3.81M
Income from Continuing Operations (Quarter)
-9.28M-6.69M-10.94M-11.72M-7.21M-4.22M-1.61M-1.04M0.23M0.51M0.53M-0.86M-2.91M-6.62M-2.51M8.91M0.46M-7.47M-4.75M3.45M
Consolidated Net Income (Quarter)
-9.28M-6.69M-10.94M-11.72M-7.21M-4.22M-1.61M-1.04M0.23M0.51M0.53M-0.86M-2.91M-6.62M-2.51M8.91M0.46M-7.47M-4.75M3.45M
Income towards Parent Company (Quarter)
-9.28M-6.69M-10.94M-11.72M-7.21M-4.22M-1.61M-1.04M0.23M0.51M0.53M-0.86M-2.91M-6.62M-2.51M8.91M0.46M-7.47M-4.75M3.45M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-9.28M-6.69M-10.94M-11.72M-7.21M-4.22M-1.61M-1.04M0.23M0.51M0.53M-0.86M-2.91M-6.62M-2.51M8.91M0.46M-7.47M-4.75M3.45M
Additional items
EPS (Basic) (Quarter)
-1.40-1.01-1.31-0.36-0.38-0.22-0.040.030.010.120.12-0.32-0.65-1.41-9.3235.500.08-0.79-4.83-9.44
EPS (Weighted Average and Diluted) (Quarter)
-0.38-0.22-0.040.030.010.110.12-0.31-0.65-1.41-9.3235.500.08-0.79-4.83-9.44
Shares Outstanding (Weighted Average) (Quarter)
6.63M6.65M7.22M9.46M19.11M19.28M36.09M28.89M40.91M4.22M4.30M4.29M4.44M4.56M0.26M0.26M5.84M9.51M0.61M0.72M
Shares Outstanding (Diluted Average) (Quarter)
19.11M19.20M36.09M28.89M41.10M4.31M4.42M4.29M4.44M4.56M0.26M0.26M5.87M9.51M0.61M0.72M
EBITDA (Quarter)
-9.05M-6.49M-10.72M-11.74M-7.08M-4.22M-1.93M-1.06M0.33M0.75M0.69M-1.25M-2.69M-6.47M-2.38M8.44M0.65M-6.73M-3.98M4.66M
Tax Rate (Quarter)
-0.66%-1.15%-0.83%0.51%-0.95%-1.46%-4.69%1.61%33.24%12.39%15.41%-3.23%-4.49%-0.56%-4.89%-0.48%22.37%-1.89%-1.93%